Target intelligence / Profile preview

Novel transcript, antisense to interleukin 3 receptor subunit alpha (ENSG00000297424)

Target
ENSG00000297424
Molecular classification
Other (Antisense RNA transcript)
01

Overview

This entity is an RNA gene annotated as a "novel transcript, antisense to interleukin 3 receptor subunit alpha (IL3RA)," located on the opposite DNA strand relative to the IL3RA locus. Antisense transcripts generally have potential regulatory roles, including modulation of their sense counterpart transcripts. For protein-coding genes, antisense RNAs can influence transcription rates, nuclear processing, and RNA stability in a chromatin-dependent manner. While there is evidence that antisense transcription can modulate the dynamics of gene expression—including post-transcriptional regulation and chromatin state—the biological function and relevance of this specific antisense transcript are currently uncharacterized. There is no data supporting its role as a receptor, enzyme, transporter, or other canonical drug target. Its naming and annotation are correct, but as a target, it lacks the attributes required for established therapeutic intervention[1][5].

Other names
Novel transcript, antisense to IL3RA
02

Mechanism of action

None established for drugs; its antisense orientation might influence IL3RA gene activity via transcriptional interference, RNA pairing, or chromatin modification

03

Biological functions

Antisense transcription (potentially modulates sense transcript, i.e., IL3RA, expression or stability)
04

Disease associations

Other (no well-established associations with diseases; IL3RA itself is involved in hematologic cancers and immune disorders, but the antisense transcript has not been linked directly to any disease)

Beyond the preview

Go deeper on Novel transcript, antisense to interleukin 3 receptor subunit alpha (ENSG00000297424).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to interleukin 3 receptor subunit alpha (ENSG00000297424).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call